Hepatocellular carcinoma studies further demonstrate differential PRG expression across immune cells, such as upregulated CRADD in tumor-infiltrating Tregs versus elevated TNF in cytotoxic FGFBP2+ T cells [27–29]. This evidence concerns the gene TNF and neoplasm.